Veradermics (MANE) News
NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
119.52-4.87 (-3.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MANE news summary
We found 9 recent headlines mentioning Veradermics (MANE): 0 in the past week and 5 in the past 30 days, most often from Investing.com, Nasdaq, Seeking Alpha. For price context, MANE is down 3.92% at $119.52. The most recent story, "Veradermics reports Q3 results", was published by Seeking Alpha on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Veradermics headlines
- Veradermics reports Q3 resultsSeeking Alpha
- Veradermics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical ProgressNEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair…Business Wire
- Why is Veradermics stock climbing today?Investing.com
- Veradermics stock rises on 12-month hair growth trial dataInvesting.com
- Why This Hair Restoration Biotech's Shares Are SoaringKey PointsThe company just released positive phase 3 results for VDPHL01, an oral extended-release formulation of minoxidil.Nasdaq
- Veradermics stock surges as hair loss drug meets Phase 3 goalsInvesting.com
- Veradermics scores another late-stage trial win for hair loss therapySeeking Alpha
- Veradermics To Review Phase 3 Study 304 Results For VDPHL01 In Male Pattern Hair Loss; Stock Up(RTTNews) - Veradermics, Inc. (MANE), a late-stage biopharmaceutical company focused on therapies for pattern hair loss, announced it will review results from Part A of a Phase 3 clinical trial…NasdaqMANE, DDS
- Biotech Stocks At 52-Week Highs - PCRX +44% On Acquisition News; MANE+14%, HAE+17%, CON, HSTM(RTTNews) - The following biotech stocks reached a 52-week high on October 8, 2026, driven by catalysts such as reports of an upcoming acquisition or upcoming financial reports.NasdaqCON, HAE, HSTM, MANE